CME Group Inc. (NASDAQ:CME) Shares Bought by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 14.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 197,571 shares of the financial services provider’s stock after buying an additional 24,643 shares during the period. Allspring Global Investments Holdings LLC owned about 0.05% of CME Group worth $43,594,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. Salomon & Ludwin LLC purchased a new stake in CME Group during the first quarter worth about $28,000. Y.D. More Investments Ltd acquired a new position in CME Group during the second quarter worth $36,000. McClarren Financial Advisors Inc. boosted its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC grew its holdings in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its position in shares of CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 0.4 %

NASDAQ CME opened at $226.17 on Wednesday. The company has a market cap of $81.44 billion, a P/E ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.12. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company has a 50-day moving average of $217.70 and a 200-day moving average of $208.53.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s revenue was up 12.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.30 earnings per share. As a group, equities analysts predict that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. CME Group’s payout ratio is 52.33%.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Barclays increased their price target on shares of CME Group from $209.00 to $219.00 and gave the company an “equal weight” rating in a research report on Monday, October 7th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. TD Cowen initiated coverage on CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Finally, Citigroup boosted their price target on CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $220.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.